Acute Porphyria Drug Database

N06DX01 - Memantine
Propably not porphyrinogenic
PNP

Rationale
No data pointing to significant CYP-metabolism or CYP-induction.
Chemical description
NMDA (N-methyl-D-aspartate receptor) antagonist used in Alzheimer´s disease. No data (in vitro) pointing to CYP-metabolism or CYP-induction or inhibition.

Similar drugs
Explore alternative drugs in similar therapeutic classes N06D / N06DX or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙